<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36969243</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID.</ArticleTitle><Pagination><StartPage>1080043</StartPage><MedlinePgn>1080043</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1080043</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1080043</ELocationID><Abstract><AbstractText>The gut microbiota plays a crucial role in human health and disease. Gut dysbiosis is known to be associated with increased susceptibility to respiratory diseases and modifications in the immune response and homeostasis of the lungs (the so-called gut-lung axis). Furthermore, recent studies have highlighted the possible role of dysbiosis in neurological disturbances, introducing the notion of the "gut-brain axis." During the last 2 years, several studies have described the presence of gut dysbiosis during coronavirus disease 2019 (COVID-19) and its relationship with disease severity, SARS-CoV-2 gastrointestinal replication, and immune inflammation. Moreover, the possible persistence of gut dysbiosis after disease resolution may be linked to long-COVID syndrome and particularly to its neurological manifestations. We reviewed recent evidence on the association between dysbiosis and COVID-19, investigating the possible epidemiologic confounding factors like age, location, sex, sample size, the severity of disease, comorbidities, therapy, and vaccination status on gut and airway microbial dysbiosis in selected studies on both COVID-19 and long-COVID. Moreover, we analyzed the confounding factors strictly related to microbiota, specifically diet investigation and previous use of antibiotics/probiotics, and the methodology used to study the microbiota (&#x3b1;- and &#x3b2;-diversity parameters and relative abundance tools). Of note, only a few studies focused on longitudinal analyses, especially for long-term observation in long-COVID. Lastly, there is a lack of knowledge regarding the role of microbiota transplantation and other therapeutic approaches and their possible impact on disease progression and severity. Preliminary data seem to suggest that gut and airway dysbiosis might play a role in COVID-19 and in long-COVID neurological symptoms. Indeed, the development and interpretation of these data could have important implications for future preventive and therapeutic strategies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Ancona, Alagna, Alteri, Palomba, Tonizzo, Pastena, Muscatello, Gori and Bandera.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ancona</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alagna</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alteri</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multimodal Research Area, Bambino Ges&#xf9; Children Hospital (IRCCS), Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palomba</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, Centre for Multidisciplinary Research in Health Science (MACH), University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tonizzo</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, Centre for Multidisciplinary Research in Health Science (MACH), University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pastena</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, Centre for Multidisciplinary Research in Health Science (MACH), University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muscatello</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gori</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, Centre for Multidisciplinary Research in Health Science (MACH), University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bandera</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, Centre for Multidisciplinary Research in Health Science (MACH), University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064806" MajorTopicYN="N">Dysbiosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">dysbiosis</Keyword><Keyword MajorTopicYN="N">gut-brain-axis</Keyword><Keyword MajorTopicYN="N">gut-lung-axis</Keyword><Keyword MajorTopicYN="N">long Covid</Keyword><Keyword MajorTopicYN="N">microbiome</Keyword><Keyword MajorTopicYN="N">microbiota</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>28</Day><Hour>19</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>27</Day><Hour>3</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36969243</ArticleId><ArticleId IdType="pmc">PMC10030519</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1080043</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organisation . WHO coronavirus disease (COVID-19) dash-board. (2022) 2022:2022.</Citation></Reference><Reference><Citation>National Institutes of Health . Treatment guidelines panel. Coronavirus disease 2019 (COVID-19). (2021) 2019:1&#x2013;243.</Citation><ArticleIdList><ArticleId IdType="pubmed">34003615</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenthal N, Cao Z, Gundrum J, Sianis J, Safo S. Risk factors associated with in-hospital mortality in a US national sample of patients with COVID-19. JAMA Netw Open (2020) 3(12):1&#x2013;14. doi: 10.1001/jamanetworkopen.2020.29058</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.29058</ArticleId><ArticleId IdType="pmc">PMC7729428</ArticleId><ArticleId IdType="pubmed">33301018</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention . Long COVID or post-COVID conditions. (2022) 2022:.</Citation></Reference><Reference><Citation>Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post-COVID-19 symptom burden: What is long-COVID and how should we manage it? Lung (2021) 199(2):113&#x2013;9. doi: 10.1007/s00408-021-00423-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00423-z</ArticleId><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanou M-I, Palaiodimou L, Bakola E, Smyrnis N, Papadopoulou M, Paraskevas GP, et al. . Neurological manifestations of long-COVID syndrome: A narrative review. Ther Adv Chronic Dis. Tsivgoulis MG and G. (2022) 13:20406223221076890. doi:&#xa0;10.1177/20406223221076890</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20406223221076890</ArticleId><ArticleId IdType="pmc">PMC8859684</ArticleId><ArticleId IdType="pubmed">35198136</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. . Clinical features of patients infected with 2019 novel coronavirus in wuhan, China. Lancet (2020) 395(10223):497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung KS, Hung IFN, Chan PPY, Lung KC, Tso E, Liu R, et al. . Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: Systematic review and meta-analysis. Gastroenterology (2020) 159(1):81&#x2013;95. doi: 10.1053/j.gastro.2020.03.065</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.03.065</ArticleId><ArticleId IdType="pmc">PMC7194936</ArticleId><ArticleId IdType="pubmed">32251668</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, et al. . Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology (2020) 159(3):944&#x2013;955.e8. doi: 10.1053/j.gastro.2020.05.048</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajili&#x107;-Stojanovi&#x107; M, de Vos WM. The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev (2014) 38(5):996&#x2013;1047. doi: 10.1111/1574-6976.12075</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1574-6976.12075</ArticleId><ArticleId IdType="pmc">PMC4262072</ArticleId><ArticleId IdType="pubmed">24861948</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JY, Tsolis RM, B&#xe4;umler AJ. The microbiome and gut homeostasis. Sci (80- ). (2022) 377(6601). doi: 10.1126/science.abp9960</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abp9960</ArticleId><ArticleId IdType="pubmed">35771903</ArticleId></ArticleIdList></Reference><Reference><Citation>Macpherson AJ, McCoy KD. Stratification and compartmentalisation of immunoglobulin responses to commensal intestinal microbes. Semin Immunol (2013) 25(5):358&#x2013;63. doi: 10.1016/j.smim.2013.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2013.09.004</ArticleId><ArticleId IdType="pubmed">24238818</ArticleId></ArticleIdList></Reference><Reference><Citation>Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol (2017) 19(1):29&#x2013;41. doi: 10.1111/1462-2920.13589</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1462-2920.13589</ArticleId><ArticleId IdType="pubmed">27928878</ArticleId></ArticleIdList></Reference><Reference><Citation>Durack J, Lynch SV. The gut microbiome: Relationships with disease and opportunities for therapy. J Exp Med (2019) 216(1):20&#x2013;40. doi: 10.1084/jem.20180448</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20180448</ArticleId><ArticleId IdType="pmc">PMC6314516</ArticleId><ArticleId IdType="pubmed">30322864</ArticleId></ArticleIdList></Reference><Reference><Citation>Adak A, Khan MR. An insight into gut microbiota and its functionalities. Cell Mol Life Sci (2019) 76(3):473&#x2013;93. doi: 10.1007/s00018-018-2943-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-018-2943-4</ArticleId><ArticleId IdType="pmc">PMC11105460</ArticleId><ArticleId IdType="pubmed">30317530</ArticleId></ArticleIdList></Reference><Reference><Citation>Suez J, Cohen Y, Vald&#xe9;s-Mas R, Mor U, Dori-Bachash M, Federici S, et al. . Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance. Cell (2022) 185(18):3307&#x2013;3328.e19. doi: 10.1016/j.cell.2022.07.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.07.016</ArticleId><ArticleId IdType="pubmed">35987213</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnenburg ED, Smits SA, Tikhonov M, Higginbottom SK, Wingreen NS, Sonnenburg JL. Diet-induced extinctions in the gut microbiota compound over generations. In: Nature. (2016) p:212&#x2013;5. doi: 10.1038/nature16504</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature16504</ArticleId><ArticleId IdType="pmc">PMC4850918</ArticleId><ArticleId IdType="pubmed">26762459</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg G, Rybakova D, Fischer D, Cernava T, Verg&#xe8;s MCC, Charles T, et al. . Microbiome definition re-visited: Old concepts and new challenges. Microbiome (2020) 8(1):1&#x2013;22. doi:&#xa0;10.1186/s40168-020-00875-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-020-00875-0</ArticleId><ArticleId IdType="pmc">PMC7329523</ArticleId><ArticleId IdType="pubmed">32605663</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou K, Wu ZX, Chen XY, Wang JQ, Zhang D, Xiao C, et al. . Microbiota in health and diseases. Signal Transduct Target Ther (2022) 7(1):135. doi: 10.1038/s41392-022-00974-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00974-4</ArticleId><ArticleId IdType="pmc">PMC9034083</ArticleId><ArticleId IdType="pubmed">35461318</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathieu E, Escribano-Vazquez U, Descamps D, Cherbuy C, Langella P, Riffault S, et al. . Paradigms of lung microbiota functions in health and disease, particularly, in asthma. Front Physiol (2018) 9:1168. doi: 10.3389/fphys.2018.01168</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.01168</ArticleId><ArticleId IdType="pmc">PMC6110890</ArticleId><ArticleId IdType="pubmed">30246806</ArticleId></ArticleIdList></Reference><Reference><Citation>Wypych TP, Wickramasinghe LC, Marsland BJ. The influence of the microbiome on respiratory health. Nat Immunol (2019) 20(10):1279&#x2013;90. doi: 10.1038/s41590-019-0451-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-019-0451-9</ArticleId><ArticleId IdType="pubmed">31501577</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouraux S, Bernasconi E, Pattaroni C, Koutsokera A, Aubert JD, Claustre J, et al. . Airway microbiota signals anabolic and catabolic remodeling in the transplanted lung. J Allergy Clin Immunol (2018) 141(2):718&#x2013;729.e7. doi:&#xa0;10.1016/j.jaci.2017.06.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2017.06.022</ArticleId><ArticleId IdType="pmc">PMC5792246</ArticleId><ArticleId IdType="pubmed">28729000</ArticleId></ArticleIdList></Reference><Reference><Citation>Sze MA, Tsuruta M, Yang SWJ, Oh Y, Man SFP, Hogg JC, et al. . Changes in the bacterial microbiota in gut, blood, and lungs following acute LPS instillation into mice lungs. PloS One (2014) 9(10):e111228. doi: 10.1371/journal.pone.0111228</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0111228</ArticleId><ArticleId IdType="pmc">PMC4205020</ArticleId><ArticleId IdType="pubmed">25333938</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichinohe T, Pang IK, Kumamoto Y, Peaper DR, Ho JH, Murray TS, et al. . Microbiota regulates immune defense against respiratory tract influenza a virus infection. Proc Natl Acad Sci USA 2011. 108(13):5354&#x2013;9. doi: 10.1073/pnas.1019378108</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1019378108</ArticleId><ArticleId IdType="pmc">PMC3069176</ArticleId><ArticleId IdType="pubmed">21402903</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Mao K, Chen X, Sun MA, Kawabe T, Li W, et al. . S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense. Science (2018) 359(6371):114&#x2013;9. doi: 10.1126/science.aam5809</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aam5809</ArticleId><ArticleId IdType="pmc">PMC6956613</ArticleId><ArticleId IdType="pubmed">29302015</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasteiger G, Fan X, Dikiy S, Lee SY, Rudensky AY. Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs. Science (2015) 350(6263):981&#x2013;5. doi: 10.1126/science.aac9593</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aac9593</ArticleId><ArticleId IdType="pmc">PMC4720139</ArticleId><ArticleId IdType="pubmed">26472762</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R, Chandrashekharappa S, Bodduluri SR, Baby BV, Hegde B, Kotla NG, et al. . Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway. Nat Commun (2019) 10(1):1&#x2013;18. doi: 10.1038/s41467-018-07859-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-07859-7</ArticleId><ArticleId IdType="pmc">PMC6327034</ArticleId><ArticleId IdType="pubmed">30626868</ArticleId></ArticleIdList></Reference><Reference><Citation>Zelante T, Iannitti RG, Cunha C, DeLuca A, Giovannini G, Pieraccini G, et al. . Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity (2013) 39(2):372&#x2013;85. doi: 10.1016/j.immuni.2013.08.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2013.08.003</ArticleId><ArticleId IdType="pubmed">23973224</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomaa EZ. Human gut microbiota/microbiome in health and diseases: A review. Antonie van Leeuwenhoek Int J Gen Mol Microbiol (2020) 113(12):2019&#x2013;40. doi: 10.1007/s10482-020-01474-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10482-020-01474-7</ArticleId><ArticleId IdType="pubmed">33136284</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratto D, Roda E, Romeo M, Venuti MT, Desiderio A, Lupo G, et al. . The many ages of microbiome&#x2013;Gut&#x2013;Brain axis. Nutrients (2022) 14(14):1&#x2013;22. doi: 10.3390/nu14142937</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14142937</ArticleId><ArticleId IdType="pmc">PMC9319041</ArticleId><ArticleId IdType="pubmed">35889894</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinan TG, Cryan JF. Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration. J Physiol (2017) 595(2):489&#x2013;503. doi: 10.1113/JP273106</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP273106</ArticleId><ArticleId IdType="pmc">PMC5233671</ArticleId><ArticleId IdType="pubmed">27641441</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeder BO, B&#xe4;ckhed F. Signals from the gut microbiota to distant organs in physiology and disease. Nat Med (2016) 22(10):1079&#x2013;89. doi: 10.1038/nm.4185</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4185</ArticleId><ArticleId IdType="pubmed">27711063</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaiss CA, Zeevi D, Levy M, Zilberman-Schapira G, Suez J, Tengeler AC, et al. . Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis. Cell (2014) 159(3):514&#x2013;29. doi: 10.1016/j.cell.2014.09.048</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.09.048</ArticleId><ArticleId IdType="pubmed">25417104</ArticleId></ArticleIdList></Reference><Reference><Citation>Matenchuk BA, Mandhane PJ, Kozyrskyj AL. Sleep, circadian rhythm, and gut microbiota. Sleep Med Rev (2020) 53:101340. doi: 10.1016/j.smrv.2020.101340</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smrv.2020.101340</ArticleId><ArticleId IdType="pubmed">32668369</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaczmarek JL, Musaad SMA, Holscher HD. Time of day and eating behaviors are associated with the composition and function of the human gastrointestinal microbiota. Am J Clin Nutr (2017) 106(5):1220&#x2013;31. doi: 10.3945/ajcn.117.156380</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.117.156380</ArticleId><ArticleId IdType="pubmed">28971851</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouries J, Brescia P, Silvestri A, Spadoni I, Sorribas M, Wiest R, et al. . Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development. J Hepatol (2019) 71(6):1216&#x2013;28. doi: 10.1016/j.jhep.2019.08.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2019.08.005</ArticleId><ArticleId IdType="pmc">PMC6880766</ArticleId><ArticleId IdType="pubmed">31419514</ArticleId></ArticleIdList></Reference><Reference><Citation>Spadoni I, Zagato E, Bertocchi A, Paolinelli R, Hot E, Di Sabatino A, et al. . A gut-vascular barrier controls the systemic dissemination of bacteria. Sci (80- ). (2015) 350(6262):830&#x2013;4. doi: 10.1126/science.aad0135</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad0135</ArticleId><ArticleId IdType="pubmed">26564856</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu L, Tong Y, Shen G, Fu A, Lai Y, Zhou X, et al. . Immunodepletion with hypoxemia: A potential high risk subtype of coronavirus disease 2019. medRxiv (2020). doi:&#xa0;10.1101/2020.03.03.20030650v1.abstract</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.03.20030650v1.abstract</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang L, Gu S, Gong Y, Li B, Lu H, Li Q, et al. . Clinical significance of the correlation between changes in the major intestinal bacteria species and COVID-19 severity. Engineering (2020) 6(10):1178&#x2013;84. doi: 10.1016/j.eng.2020.05.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eng.2020.05.013</ArticleId><ArticleId IdType="pmc">PMC7832131</ArticleId><ArticleId IdType="pubmed">33520333</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Liu Q, Zhang F, Lui GCY, Tso EYK, Yeoh YK, et al. . Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19. Gut (2021) 70(2):276&#x2013;84. doi:&#xa0;10.1136/gutjnl-2020-322294</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-322294</ArticleId><ArticleId IdType="pmc">PMC7385744</ArticleId><ArticleId IdType="pubmed">32690600</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu S, Chen Y, Wu Z, Chen Y, Gao H, Lv L, et al. . Alterations of the gut microbiota in patients with COVID-19 or H1N1 influenza silan. Journals Gerontol Ser A Biol Sci Med Sci (2020) 0813:1&#x2013;11. doi:&#xa0;10.1093/cid/ciaa709</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa709</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao W, Zhang G, Wang X, Guo M, Zeng W, Xu Z, et al. . Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18. Med Microecol (2020) 5(September):100023. doi:&#xa0;10.1016/j.medmic.2020.100023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medmic.2020.100023</ArticleId><ArticleId IdType="pmc">PMC7832617</ArticleId><ArticleId IdType="pubmed">34173452</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh YK, Zuo T, Lui GCY, Zhang F, Liu Q, Li AYL, et al. . Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut (2021) 70(4):698&#x2013;706. doi: 10.1136/gutjnl-2020-323020</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzarelli A, Giancola ML, Farina A, Marchioni L, Rueca M, Gruber CEM, et al. . 16S rRNA gene sequencing of rectal swab in patients affected by COVID-19. PloS One (2021) 16:1&#x2013;15. doi:&#xa0;10.1371/journal.pone.0247041</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0247041</ArticleId><ArticleId IdType="pmc">PMC7888592</ArticleId><ArticleId IdType="pubmed">33596245</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, Ye S, Zhu X, He X, Wang S, Li Y, et al. . Gastrointestinal disturbance and effect of fecal microbiota transplantation in discharged COVID-19 patients. J Med Case Rep (2021) 15(1):1&#x2013;9. doi:&#xa0;10.1186/s13256-020-02583-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13256-020-02583-7</ArticleId><ArticleId IdType="pmc">PMC7868905</ArticleId><ArticleId IdType="pubmed">33557941</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu R, Lu R, Zhang T, Wu Q, Cai W, Han X, et al. . Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults. Commun Biol (2021) 4(1):1&#x2013;11. doi: 10.1038/s42003-021-01796-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-01796-w</ArticleId><ArticleId IdType="pmc">PMC7893062</ArticleId><ArticleId IdType="pubmed">33603076</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Z, Wang H, Cui G, Lu H, Wang L, Luo H, et al. . Alterations in the human oral and gut microbiomes and lipidomics in COVID-19. Gut (2021) 70(7):1253&#x2013;65. doi: 10.1136/gutjnl-2020-323826</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323826</ArticleId><ArticleId IdType="pmc">PMC8042598</ArticleId><ArticleId IdType="pubmed">33789966</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Gu S, Chen Y, Lu H, Shi D, Guo J, et al. . Six-month follow-up of gut microbiota richness in patients with COVID-19. Gut (2022) 71(1):222&#x2013;5. doi: 10.1136/gutjnl-2021-324090</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324090</ArticleId><ArticleId IdType="pmc">PMC8666823</ArticleId><ArticleId IdType="pubmed">33833065</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaibani P, D&#x2019;Amico F, Bartoletti M, Lombardo D, Rampelli S, Fornaro G, et al. . The gut microbiota of critically ill patients with COVID-19. Front Cell Infect Microbiol (2021) 11(June):1&#x2013;11. doi: 10.3389/fcimb.2021.670424</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.670424</ArticleId><ArticleId IdType="pmc">PMC8276076</ArticleId><ArticleId IdType="pubmed">34268136</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Shi X, Fu W, Xiang F, He X, Yang B, et al. . Gut microbiota dysbiosis correlates with abnormal immune response in moderate covid-19 patients with fever. J Inflammation Res (2021) 14:2619&#x2013;31. doi: 10.2147/JIR.S311518</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S311518</ArticleId><ArticleId IdType="pmc">PMC8217908</ArticleId><ArticleId IdType="pubmed">34168484</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HN, Joo EJ, Lee CW, Ahn KS, Kim HL, Park D, et al. . Reversion of gut microbiota during the recovery phase in patients with asymptomatic or mild covid-19: Longitudinal study. Microorganisms (2021) 9(6):1&#x2013;16. doi: 10.3390/microorganisms9061237</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9061237</ArticleId><ArticleId IdType="pmc">PMC8228238</ArticleId><ArticleId IdType="pubmed">34200249</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Zhang J, Zhang D, Ma WL, Wang X. Linking the gut microbiota to persistent symptoms in survivors of COVID-19 after discharge. J Microbiol (2021) 59(10):941&#x2013;8. doi: 10.1007/s12275-021-1206-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12275-021-1206-5</ArticleId><ArticleId IdType="pmc">PMC8356893</ArticleId><ArticleId IdType="pubmed">34382150</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreira-Ros&#xe1;rio A, Marques C, Pinheiro H, Ara&#xfa;jo JR, Ribeiro P, Rocha R, et al. . Gut microbiota diversity and c-reactive protein are predictors of disease severity in COVID-19 patients. Front Microbiol (2021) 12:1&#x2013;13. doi: 10.3389/fmicb.2021.705020</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.705020</ArticleId><ArticleId IdType="pmc">PMC8326578</ArticleId><ArticleId IdType="pubmed">34349747</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Cheng X, Jiang G, Tang H, Ming S, Tang L, et al. . Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization. NPJ Biofilms Microbiomes (2021) 7(1):90. doi: 10.1038/s41522-021-00262-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41522-021-00262-z</ArticleId><ArticleId IdType="pmc">PMC8298611</ArticleId><ArticleId IdType="pubmed">34294722</ArticleId></ArticleIdList></Reference><Reference><Citation>He F, Zhang T, Xue K, Fang Z, Jiang G, Huang S, et al. . Fecal multi-omics analysis reveals diverse molecular alterations of gut ecosystem in COVID-19 patients. Anal Chim Acta (2021) 1180:338881. doi: 10.1016/j.aca.2021.338881</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aca.2021.338881</ArticleId><ArticleId IdType="pmc">PMC8310733</ArticleId><ArticleId IdType="pubmed">34538334</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Yang S, Zhou Y, Disoma C, Dong Z, Du A, et al. . Microbiome profiling using shotgun metagenomic sequencing identified unique microorganisms in COVID-19 patients with altered gut microbiota. Front Microbiol (2021) 12(October). doi: 10.3389/fmicb.2021.712081</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.712081</ArticleId><ArticleId IdType="pmc">PMC8542975</ArticleId><ArticleId IdType="pubmed">34707577</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Mak JWY, Su Q, Yeoh YK, Lui GCY, Ng SSS, et al. . Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut (2022) 71(3):544&#x2013;52. doi: 10.1136/gutjnl-2021-325989</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng SC, Peng Y, Zhang L, Mok CK, Zhao S, Li A, et al. . Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events. Gut (2022) 71(6):1106&#x2013;16. doi: 10.1136/gutjnl-2021-326563</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-326563</ArticleId><ArticleId IdType="pmc">PMC8844967</ArticleId><ArticleId IdType="pubmed">35140064</ArticleId></ArticleIdList></Reference><Reference><Citation>Zmora N, Suez J, Elinav E. You are what you eat: Diet, health and the gut microbiota. Nat Rev Gastroenterol Hepatol (2019) 16(1):35&#x2013;56. doi: 10.1038/s41575-018-0061-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-018-0061-2</ArticleId><ArticleId IdType="pubmed">30262901</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh RK, Chang HW, Yan D, Lee KM, Ucmak D, Wong K, et al. . Influence of diet on the gut microbiome and implications for human health. J Transl Med (2017) 15(1):1&#x2013;17. doi: 10.1186/s12967-017-1175-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-017-1175-y</ArticleId><ArticleId IdType="pmc">PMC5385025</ArticleId><ArticleId IdType="pubmed">28388917</ArticleId></ArticleIdList></Reference><Reference><Citation>Noguera-Julian M, Rocafort M, Guill&#xe9;n Y, Rivera J, Casadell&#xe0; M, Nowak P, et al. . Gut microbiota linked to sexual preference and HIV infection. EBioMedicine (2016) 5:135&#x2013;46. doi: 10.1016/j.ebiom.2016.01.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2016.01.032</ArticleId><ArticleId IdType="pmc">PMC4816837</ArticleId><ArticleId IdType="pubmed">27077120</ArticleId></ArticleIdList></Reference><Reference><Citation>Neff CP, Krueger O, Xiong K, Arif S, Nusbacher N, Schneider JM, et al. . Fecal microbiota composition drives immune activation in HIV-infected individuals. EBioMedicine (2018) 30:192&#x2013;202. doi: 10.1016/j.ebiom.2018.03.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2018.03.024</ArticleId><ArticleId IdType="pmc">PMC5952409</ArticleId><ArticleId IdType="pubmed">29650491</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill TCJ, Walsh KA, Harris JA, Moffett BF. Using ecological diversity measures with bacterial communities. FEMS Microbiol Ecol (2003) 43(1):1&#x2013;11. doi: 10.1111/j.1574-6941.2003.tb01040.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6941.2003.tb01040.x</ArticleId><ArticleId IdType="pubmed">19719691</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y, Zhou BJ, Deng GH, Jiang XT, Zhang H, Zhou HW. Comparison of microbial diversity determined with the same variable tag sequence extracted from two different PCR amplicons. BMC Microbiol (2013) 13(1):1. doi: 10.1186/1471-2180-13-208</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2180-13-208</ArticleId><ArticleId IdType="pmc">PMC3848352</ArticleId><ArticleId IdType="pubmed">24034943</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregorius HR. Effective numbers in the partitioning of biological diversity. J Theor Biol (2016) 409:133&#x2013;47. doi: 10.1016/j.jtbi.2016.08.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtbi.2016.08.037</ArticleId><ArticleId IdType="pubmed">27596530</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozupone CA, Hamady M, Kelley ST, Knight R. Quantitative and qualitative &#x3b2; diversity measures lead to different insights into factors that structure microbial communities. Appl Environ Microbiol (2007) 73(5):1576&#x2013;85. doi: 10.1128/AEM.01996-06</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.01996-06</ArticleId><ArticleId IdType="pmc">PMC1828774</ArticleId><ArticleId IdType="pubmed">17220268</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirayama M, Nishiwaki H, Hamaguchi T, Ito M, Ueyama J, Maeda T, et al. . Intestinal collinsella may mitigate infection and exacerbation of COVID-19 by producing ursodeoxycholate. PloS One (2021) 16(11 November):1&#x2013;11. doi: 10.1371/journal.pone.0260451</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0260451</ArticleId><ArticleId IdType="pmc">PMC8610263</ArticleId><ArticleId IdType="pubmed">34813629</ArticleId></ArticleIdList></Reference><Reference><Citation>De Maio F, Posteraro B, Ponziani FR, Cattani P, Gasbarrini A, Sanguinetti M. Nasopharyngeal microbiota profiling of SARS-CoV-2 infected patients. Biol Proced Online. (2020) 22(1):20&#x2013;3. doi:&#xa0;10.1186/s12575-020-00131-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12575-020-00131-7</ArticleId><ArticleId IdType="pmc">PMC7382556</ArticleId><ArticleId IdType="pubmed">32728349</ArticleId></ArticleIdList></Reference><Reference><Citation>Rueca M, Fontana A, Bartolini B, Piselli P, Mazzarelli A, Copetti M, et al. . Investigation of nasal/oropharyngeal microbial community of covid-19 patients by 16s rdna sequencing. Int J Environ Res Public Health (2021) 18(4):1&#x2013;12. doi: 10.3390/ijerph18042174</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18042174</ArticleId><ArticleId IdType="pmc">PMC7926517</ArticleId><ArticleId IdType="pubmed">33672177</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Z, Xiao Y, Kang L, Ma W, Shi L, Zhang L, et al. . Genomic diversity of severe acute respiratory syndrome-coronavirus 2 in patients with coronavirus disease 2019. Clin Infect Dis (2020) 71(15):713&#x2013;20. doi: 10.1093/cid/ciaa203</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa203</ArticleId><ArticleId IdType="pmc">PMC7108196</ArticleId><ArticleId IdType="pubmed">32129843</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardelli C, Gentile I, Setaro M, Di Domenico C, Pinchera B, Buonomo AR, et al. . Nasopharyngeal microbiome signature in COVID-19 positive patients: Can we definitively get a role to fusobacterium periodonticum? Front Cell Infect Microbiol (2021) 11:1&#x2013;7. doi:&#xa0;10.3389/fcimb.2021.625581</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.625581</ArticleId><ArticleId IdType="pmc">PMC7919745</ArticleId><ArticleId IdType="pubmed">33659220</ArticleId></ArticleIdList></Reference><Reference><Citation>Budding A, Sieswerda E, Wintermans B, Bos M. An Age Dependent Pharyngeal Microbiota Signature Associated with SARS-CoV-2 Infection. (2020). doi:&#xa0;10.2139/ssrn.3582780</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3582780</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventero MP, Cuadrat RRC, Vidal I, Andrade BGN, Molina-Pardines C, Haro-Moreno JM, et al. . Nasopharyngeal microbial communities of patients infected with SARS-CoV-2 that developed COVID-19. Front Microbiol (2021) 12:1&#x2013;10. doi:&#xa0;10.3389/fmicb.2021.637430</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.637430</ArticleId><ArticleId IdType="pmc">PMC8010661</ArticleId><ArticleId IdType="pubmed">33815323</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosas-Salazar C, Kimura KS, Shilts MH, Strickland BA, Freeman MH, Wessinger BC, et al. . SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome. J Allergy Clin Immunol (2021) 147(4):1226&#x2013;1233.e2. doi:&#xa0;10.1016/j.jaci.2021.02.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2021.02.001</ArticleId><ArticleId IdType="pmc">PMC7871823</ArticleId><ArticleId IdType="pubmed">33577896</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao Q, Ma Y, Ling Y, Jin W, Su Y, Wang Q, et al. . Evaluation of superinfection, antimicrobial usage, and airway microbiome with metagenomic sequencing in COVID-19 patients: A cohort study in shanghai. J Microbiol Immunol Infect (2021) 54(5):808&#x2013;15. doi:&#xa0;10.1016/j.jmii.2021.03.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2021.03.015</ArticleId><ArticleId IdType="pmc">PMC8021444</ArticleId><ArticleId IdType="pubmed">34103263</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun T, Halevi S, Hadar R, Efroni G, Glick Saar E, Keller N, et al. . SARS-CoV-2 does not have a strong effect on the nasopharyngeal microbial composition. Sci Rep [Internet]. (2021) 11(1):8922. doi:&#xa0;10.1038/s41598-021-88536-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-88536-6</ArticleId><ArticleId IdType="pmc">PMC8076218</ArticleId><ArticleId IdType="pubmed">33903709</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Ai JW, Yang W, Zhou X, He F, Xie S, et al. . Metatranscriptomic characterization of coronavirus disease 2019 identified a host transcriptional classifier associated with immune signaling. Clin Infect Dis (2021) 73(3):376&#x2013;85. doi: 10.1093/cid/ciaa663</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa663</ArticleId><ArticleId IdType="pmc">PMC7314197</ArticleId><ArticleId IdType="pubmed">32463434</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafa HH, Fissel JA, Fanelli B, Bergman Y, Gniazdowski V, Dadlani M, et al. . Metagenomic next-generation sequencing of nasopharyngeal specimens collected from confirmed and suspect covid-19 patients. MBio (2020) 11(6):1&#x2013;13. doi: 10.1128/mBio.01969-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01969-20</ArticleId><ArticleId IdType="pmc">PMC7686804</ArticleId><ArticleId IdType="pubmed">33219095</ArticleId></ArticleIdList></Reference><Reference><Citation>Merenstein C, Liang G, Whiteside SA, Cobi&#xe1;n-G&#xfc;emes AG, Merlino MS, Taylor LJ, et al. . Signatures of COVID-19 severity and immune response in the respiratory tract microbiome. ASM J MBio (2021) 12(4). doi: 10.1128/mBio.01777-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01777-21</ArticleId><ArticleId IdType="pmc">PMC8406335</ArticleId><ArticleId IdType="pubmed">34399607</ArticleId></ArticleIdList></Reference><Reference><Citation>Geva-Zatorsky N, Sefik E, Kua L, Pasman L, Tan TG, Ortiz-Lopez A, et al. . Mining the human gut microbiota for immunomodulatory organisms. Cell (2017) 168(5):928&#x2013;943.e11. doi: 10.1016/j.cell.2017.01.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.01.022</ArticleId><ArticleId IdType="pmc">PMC7774263</ArticleId><ArticleId IdType="pubmed">28215708</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramanan P, Barreto JN, Osmon DR, Tosh PK. Rothia bacteremia: A 10-year experience at Mayo clinic, Rochester, Minnesota. J Clin Microbiol (2014) 52(9):3184&#x2013;9. doi: 10.1128/JCM.01270-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01270-14</ArticleId><ArticleId IdType="pmc">PMC4313135</ArticleId><ArticleId IdType="pubmed">24951810</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard-Raichon L, Venzon M, Klein J, Axelrad JE, Zhang C, Sullivan AP, et al. . Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia. Nat Commun (2022) 13(1):1&#x2013;13. doi: 10.1038/s41467-022-33395-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33395-6</ArticleId><ArticleId IdType="pmc">PMC9626559</ArticleId><ArticleId IdType="pubmed">36319618</ArticleId></ArticleIdList></Reference><Reference><Citation>Seibert B, C&#xe1;ceres CJ, Cardenas-Garcia S, Carnaccini S, Geiger G, Rajao DS, et al. . Mild and severe SARS-CoV-2 infection induces respiratory and intestinal microbiome changes in the K18-hACE2 transgenic mouse model. Microbiol Spectr (2021) 9(1):e00536-21. doi:&#xa0;10.1128/Spectrum.00536-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/Spectrum.00536-21</ArticleId><ArticleId IdType="pmc">PMC8455067</ArticleId><ArticleId IdType="pubmed">34378965</ArticleId></ArticleIdList></Reference><Reference><Citation>Bercik P, Denou E, Collins J, Jackson W, Lu J, Jury J, et al. . The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology (2011) 141(2):599&#x2013;609. doi: 10.1053/j.gastro.2011.04.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2011.04.052</ArticleId><ArticleId IdType="pubmed">21683077</ArticleId></ArticleIdList></Reference><Reference><Citation>Carloni S, Bertocchi A, Mancinelli S, Bellini M, Erreni M, Borreca A, et al. . Identification of a choroid plexus vascular barrier closing during intestinal inflammation. Science (2021) 374(6566):439&#x2013;48. doi:&#xa0;10.1126/science.abc6108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc6108</ArticleId><ArticleId IdType="pubmed">34672740</ArticleId></ArticleIdList></Reference><Reference><Citation>Agirman G, Yu KB, Hsiao EYT. Signaling inflammation across the gut-brain axis. (2021) 1092:1087&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">34822299</ArticleId></ArticleIdList></Reference><Reference><Citation>Sajdel-Sulkowska EM. Neuropsychiatric ramifications of COVID-19: Short-chain fatty acid deficiency and disturbance of microbiota-Gut-Brain axis signaling. BioMed Res Int (2021) 2021:7880448. doi: 10.1155/2021/7880448</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/7880448</ArticleId><ArticleId IdType="pmc">PMC8510788</ArticleId><ArticleId IdType="pubmed">34651049</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao N, Nie M, Pang H, Wang B, Hu J, Meng X, et al. . Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications. Nat Commun (2021) 12(1):1&#x2013;13. doi: 10.1038/s41467-021-21907-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21907-9</ArticleId><ArticleId IdType="pmc">PMC7955129</ArticleId><ArticleId IdType="pubmed">33712622</ArticleId></ArticleIdList></Reference><Reference><Citation>Nataf S, Pays L. Molecular insights into sars-cov2-induced alterations of the gut/brain axis. Int J Mol Sci (2021) 22(19):10440. doi: 10.3390/ijms221910440</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms221910440</ArticleId><ArticleId IdType="pmc">PMC8508788</ArticleId><ArticleId IdType="pubmed">34638785</ArticleId></ArticleIdList></Reference><Reference><Citation>Drakopanagiotakis F, Stavropoulou E, Tsigalou C, Nena E, Steiropoulos P. The role of the microbiome in connective-Tissue-Associated interstitial lung disease and pulmonary vasculitis. Biomed (2022) 10(12):3195. doi: 10.3390/biomedicines10123195</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10123195</ArticleId><ArticleId IdType="pmc">PMC9775480</ArticleId><ArticleId IdType="pubmed">36551951</ArticleId></ArticleIdList></Reference><Reference><Citation>Din AU, Mazhar M, Wasim M, Ahmad W, Bibi A, Hassan A, et al. . SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role. BioMed Pharmacother (2021) 133:110947. doi: 10.1016/j.biopha.2020.110947</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110947</ArticleId><ArticleId IdType="pmc">PMC7657099</ArticleId><ArticleId IdType="pubmed">33197765</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>